Cite
HARVARD Citation
Nakamura, M. et al. (2021). Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation. British journal of haematology. pp. 403-413. [Online].